Form 4 for MRK Merck & Co.
Accepted 2026-05-01 17:38:12 ET · period of report 2026-04-29 · accession 0000310158-26-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-01 17:38 | 2026-04-29 | MRK | Davis Robert M | COB, CEO, Pres, Dir | M - OptEx | $110.03 | +13.3K | 456.9K | +3% | +$1.46M |
| D | 2026-05-01 17:38 | 2026-04-29 | MRK | Davis Robert M | COB, CEO, Pres, Dir | F - Tax | $110.03 | -6,551 | 450.4K | -1% | -$720.8K |
| D | 2026-05-01 17:38 | 2026-04-29 | MRK | Davis Robert M | COB, CEO, Pres, Dir | M - OptEx | $0.00 | -13.3K | 26.6K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-29 | M | A | 13,300 | $110.03 | 456,901.76 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-29 | F | D | 6,551 | $110.03 | 450,350.76 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-04-29 | M | D | 13,300 | $0.00 | 26,601 | D | — · 2026-04-29 to 2028-04-29 | 13,300 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. |